University of Calgary

Research team earns AHS President’s Excellence Award

UToday HomeMay 14, 2012

(Left to right) Drs. Marcello Tonelli, Brenda Hemmelgarn and Braden Manns received the AHS President’s Excellence Award for Outstanding Achievements in Research for their research into chronic diseases which has yielded significant results for patients. Photo courtesy of AHSThree Alberta medical researchers focused on improving the quality of care for people with chronic diseases have been named the recipients of the first Alberta Health Services President’s Excellence Award for Outstanding Achievements in Research.

Two of the three are associate professors at the Faculty of Medicine.

Dr. Brenda Hemmelgarn and Dr. Braden Manns—from the departments of medicine and community health sciences and members of the Institute for Public Health—led the Interdisciplinary Chronic Disease Collaboration (ICDC) along with the University of Alberta’s Marcello Tonelli. The group aims to support higher quality, more equitable, efficient care for Albertans with, or at risk of, common chronic ailments such as kidney disease, diabetes and heart disease.

“Our research has always focused on informing health care policy, and so receiving recognition from one of our most important partners is particularly satisfying and rewarding,” says Manns, who along with his partners will be presented with a certificate and an award at a future luncheon.

The project will receive a one-time discretionary budget allocation to advance further innovative work.

AHS president and CEO Chris Eagle says the team’s research, which includes consultation with front-line physicians and practitioners, is helping improve the quality of care for Albertans.

“By focusing their research on current and emerging issues related to chronic diseases, and then providing sound conclusions, Drs. Hemmelgarn, Manns and Tonelli are helping AHS improve both the quality and accessibility of health care services across the province,” says Eagle. “Research such as that done through this collaboration is essential to the ongoing patient care improvements we seek for AHS.”

For their part, the three researchers plan to continue their partnership with AHS in a bid to improve health outcomes for patients.

“An important part of this work is making sure that our research is relevant for what our partners need, when they need it, and is expressed in a way that they can use to make their decisions easier,” says Hemmelgarn.